| abstract |
The present invention is for use in the treatment, prevention or progression prevention of harmful cardiac remodeling and conditions resulting from or associated with myocardial infarction and pressure overload, such as heart failure, aneurysm formation and old myocardial fibrosis, and It relates to immunoglobulin (Ig) -like molecules or fragments thereof for use in improving angiogenesis, preferably angiogenesis after ischemic injury. The present invention also provides a nucleic acid molecule encoding the Ig-like molecule, a vector containing the same, and a host cell containing the same. |